SCHEMBL7595671

SCHEMBL7595671

C[C@@H]1C[C@@H](Cl)C[C@H](c2cccc(Cl)c2)N1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC9A1 P19634 1/20 0.40
HTR2A P28223 2/20 0.40
HTR2C P28335 2/20 0.40
HTR2B P41595 2/20 0.40
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
SLC6A3 Q01959 3/20 0.37
SLC6A2 P23975 1/20 0.37
KDM1A O60341 1/20 0.36
RCOR1 Q9UKL0 1/20 0.36
HTT P42858 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
MCL1 Q07820 1/20 0.36
TRPM4 Q8TD43 1/20 0.35
TRPM5 Q9NZQ8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7679914 1.00 SLC9A1 (0.40) SLC9A1HTR2AHTR2CHTR2BALDH1A1
Fumaric Acid SCHEMBL7591475 0.89 SLC9A1 (0.39) SLC9A1ALDH1A1MAPTHPGDTSHR
Fumaric Acid SCHEMBL7679544 0.89 SLC9A1 (0.39) SLC9A1ALDH1A1MAPTHPGDTSHR
Fumaric Acid SCHEMBL7679536 0.89 SLC9A1 (0.39) SLC9A1ALDH1A1MAPTHPGDTSHR
SCHEMBL6984509 0.83 ALDH1A1 (0.41) SLC9A1HTR2AHTR2CHTR2BALDH1A1
SCHEMBL7677811 0.83 ALDH1A1 (0.41) SLC9A1HTR2AHTR2CHTR2BALDH1A1
SCHEMBL6984952 0.83 ALDH1A1 (0.41) SLC9A1HTR2AHTR2CHTR2BALDH1A1
Hydrochloric Acid SCHEMBL7696213 0.82 ALDH1A1 (0.40) SLC9A1HTR2AHTR2CHTR2BALDH1A1
Hydrochloric Acid SCHEMBL7594196 0.82 ALDH1A1 (0.40) SLC9A1HTR2AHTR2CHTR2BALDH1A1
Hydrochloric Acid SCHEMBL7592478 0.82 ALDH1A1 (0.40) SLC9A1HTR2AHTR2CHTR2BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6451789-B1 CENTRAL NERVOUS SYSTEM DISORDERS; COGNITION ACTIVATORS LES LABORTOIRES SERVIER (FR) 2002-09-17 US disclosed
US-20020042413-A1 1-aza-2-alkyl-6-aryl-cycloalkanes RAULT SYLVAIN (FR) 2002-04-11 US disclosed
US-6323222-B1 COGNITION ACTIVATORS, ALZHEIMER*S DISEASE AND ENZYME INHIBITORS ADIR ET COMPAGNIE (FR) 2001-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020042413-A1 1-aza-2-alkyl-6-aryl-cycloalkanes SULT2A1, GRIN2A, NR3C1 SLC9A1 751/4885HTR2A 114/4885HTR2C 137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.